Cyramza is indicated for the treatment of cancer of the advanced stomach, lung and intestine, in the colon or rectum.
This is an anticancer medicine, which has in its composition the active substance Ramucirumab, a monoclonal antibody that recognizes and binds to proteins found in blood vessels, blocking and interrupting the blood supply to cancer cells.
How to take
The recommended doses of Cyramza should be indicated by the doctor, as they depend on the problem to be treated and the body's response to treatment.
Side effects
Some of the side effects of Cyramza may include perforation in the stomach or intestine that causes symptoms of severe abdominal pain, vomiting, fever or chills, intestinal bleeding with symptoms such as extreme tiredness, weakness, dizziness or discolored stools, bleeding from the nose, diarrhea, inflammation of the lining of the mouth or headache.
Contraindications
Cyramza is contraindicated for patients being treated with Ramucirumab, with lung cancer with a cavity or hole or located close to the large vessels, and for patients with allergies to pirfenidone or any of the components of the formula.
In addition, if you have a disease that increases the risk of bleeding, high blood pressure, liver disease or kidney problems, you should talk to your doctor before starting treatment.
